DarioHealth Corp.
DRIO Nasdaq
SEC CIK 1533998
Follow DarioHealth Corp.
Weekly email: filings, results
Revenue, last quarter
$5.3M
+6.1% vs same quarter last year
EPS, diluted
$0.73
−75.3% vs same quarter last year
Operating cash flow
−$5.5M
+24.7% vs same quarter last year
Operating income
−$8M
+15.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Revenue |
|---|---|
| FY25 | $22.4M |
| FY24 | $27M |
| FY23 | $20.4M |
| FY22 | $27.7M |
| FY21 | $20.5M |
| FY20 | $7.6M |
| FY19 | $7.6M |
| FY18 | $7.4M |
| FY17 | $5.2M |
| FY16 | $2.8M |
| FY15 | $823K |
| FY14 | $51K |
| FY13 | $0 |
| FY12 | - |
| FY11 | - |
- Gross margin
- Operating margin
Show the numbers
| Year | Gross margin | Operating margin |
|---|---|---|
| FY25 | 56.6% | −163.9% |
| FY24 | 49.1% | −213.6% |
| FY23 | 29.4% | −276.1% |
| FY22 | 34.9% | −205.4% |
| FY21 | 19.3% | −372.9% |
| FY20 | 33.2% | −394.7% |
| FY19 | 34.4% | −234.2% |
| FY18 | 23.9% | −239.2% |
| FY17 | 25.4% | −278.9% |
| FY16 | −29.6% | −396% |
| FY15 | −103.9% | −935.4% |
| FY14 | −5317.6% | −22270.6% |
| FY13 | - | - |
| FY12 | - | - |
| FY11 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$26.1M |
| FY24 | −$38.7M |
| FY23 | −$31M |
| FY22 | −$48.3M |
| FY21 | −$50.7M |
| FY20 | −$17.9M |
| FY19 | −$15.8M |
| FY18 | −$11.5M |
| FY17 | −$10.8M |
| FY16 | −$9.2M |
| FY15 | −$6.4M |
| FY14 | −$9.1M |
| FY13 | −$9M |
| FY12 | −$3.5M |
| FY11 | - |